Mutations in the insulin-like growth factor-I (IGF-I) receptor (IGF1R) have been associated with prenatal and postnatal growth retardation. However, little is known about potential effects of mutations in the IGF1R on carbohydrate homeostasis. Methods: We investigated clinical, endocrine and metabolic parameters in four family members carrying a novel IGF1R mutation (p.Tyr387X): an 18-year-old male (index case), his sister and two paternal aunts. Results: All family members showed a variable degree of impairment in prenatal growth, with birth weight standard deviation scores (SDS) between –1.65 and –2.37 and birth length SDS between –1.78 and –3.08. Their postnatal growth was also impaired, with height SDS between –1.75 and –4.86. The index case presented high IGF-I levels during childhood and adolescence and delayed bone age. The index case and his two paternal aunts had impaired glucose tolerance (IGT) associated with a variable degree of alterations in insulin sensitivity and secretion. In contrast, the index case’s sister, who had had IGT during pregnancy, showed normal glucose metabolism but reduced insulin sensitivity. Conclusion: This is the first study showing an association between a novel IGF1R mutation and a variable degree of alterations in prenatal and postnatal growth and in carbohydrate metabolism.

Despite the unprecedented improvement in child health in last 15 years, burden of stillbirth and neonatal death remain the key challenge in Nepal and the reduction of these deaths will be crucial for reaching the health targets for Sustainable development goal by 2030. The aim of this thesis was to explore the risk factors for stillbirth and neonatal death and change in perinatal outcomes after the introduction of the Helping Babies Breathe Quality Improvement Cycle (HBB QIC) in Nepal. This was a prospective cohort study with a nested case-control design completed in a tertiary hospital in Nepal. Information were collected from the women who had experienced perinatal death and live birth among referent population; a video recording was done in the neonatal resuscitation corner to collect information on the health workers’ performance in neonatal resuscitation.  Lack of antenatal care had the highest association with antepartum stillbirth (aOR 4.2, 95% CI 3.2–5.4), births that had inadequate fetal heart rate monitoring were associated with intrapartum stillbirth (aOR 1.9, CI 95% 1.5–2.4), and babies who were born premature and small-for-gestational-age had the highest risk for neonatal death in the hospital (aOR 16.2, 95% CI 12.3–21.3). Before the introduction of the HBB QIC, health workers displayed poor adherence to the neonatal resuscitation protocol. After the introduction of HBB QIC, the health workers demonstrated improvement in their neonatal resuscitation skills and these were retained until six months after training. Daily bag-and-mask skill checks (RR 5.1 95% CI 1.9–13.5), preparation for birth (RR 2.4, 95% CI 1.0–5.6), self-evaluation checklists (RR 3.8, 95% CI 1.4–9.7) and weekly review and reflection meetings (RR 2.6, 95% 1.0–7.4) helped the health workers to retain their neonatal resuscitation skills. The health workers demonstrated improvement in ventilation of babies within one minute of birth and there was a reduction in intrapartum stillbirth (aOR 0.46, 95% CI 0.32–0.66) and first-day neonatal mortality (aOR 0.51, 95% CI 0.31–0.83).  The study provides information on challenges in reducing stillbirth and neonatal death in low income settings and provides a strategy to improve health workers adherence to neonatal resuscitation to reduce the mortality. The HBB QIC can be implemented in similar clinical settings to improve quality of care and survival in Nepal, but for primary care settings, the QIC need to be evaluated further.

Résumé: Les anti-infectieux sont parmi les médicaments les plus utilisés pendant la grossesse. Les indications pour l’utilisation de ces médicaments, telles que les infections bactériennes, figurent parmi les facteurs de risque les plus importants pour la prématurité et les enfants nés petits pour l'âge gestationnel («Small-for-gestational-age », SGA). Ces complications de la grossesse peuvent avoir des incidences sur la santé du nouveau né et sur son développement futur. Compte tenu des impacts sur la santé de la mère et de l’enfant, la prise en charge et le traitement efficace de ces infections sont impératifs. Cependant, l'utilisation des anti-infectieux, pour éviter des issues de grossesse défavorables, fait l’objet d’une controverse dans la littérature. Cette controverse est en partie liée à la qualité méthodologique discutable des études disponibles sur le sujet. Les quatre études présentées dans cette thèse ont donc pour objectif d’investiguer l’utilisation des anti-infectieux durant la grossesse ainsi que d’évaluer le risque de prématurité et de SGA après utilisation de ces médicaments en période gestationnelle. Une révision systématique de la littérature sur l’utilisation du métronidazole durant la grossesse est également présentée. Nous avons utilisé, comme source de données le Registre des Grossesses du Québec, une cohorte longitudinale conçue à partir du jumelage de trois bases de données administratives de la province du Québec (RAMQ, Med-Echo et ISQ). Le registre fournit des informations sur les prescriptions, les services pharmaceutiques et médicaux, ainsi que des donnés sur les soins d’hospitalisation de courte durée et démographiques. Les deux premières études présentées dans cette thèse ont eu pour objectif d’évaluer la prévalence, les tendances, les indications et les prédicteurs de l’utilisation des anti-infectieux dans une cohorte, extraite du registre, de 97 680 femmes enceintes. A l’aide d’un devis cas-témoins, les 2 dernières études ont mesuré l’association entre l’utilisation d’anti-infectieux durant les 2 derniers trimestres de grossesse et le risque de prématurité et de SGA, respectivement. Un cas de prématurité a été défini comme un accouchement survenu avant 37 semaines de gestation. Un cas de SGA a été défini comme l’accouchement d’un enfant dont le poids à la naissance se situe sous le 10ème percentile du poids normalisé à la naissance (compte tenu de l’âge gestationnel et du sexe du bébé). Les données ont été recueillies pour les agents systémiques oraux, ainsi que pour les classes et les agents individuels. Nos résultats ont montré que la prévalence de l’utilisation des anti-infectieux durant la grossesse était comparable à celle d’autres études déjà publiées (25%). Nous avons observé une augmentation de l’utilisation des agents plus anciens et ayant des profils d’innocuité connus. Les prédicteurs de l’usage en début de grossesse identifiés sont : avoir eu plus de deux différentes prescriptions (OR ajusté = 3,83, IC 95% : 3,3-4,3), avoir eu un diagnostic d’infection urinaire (OR= 1,50, IC 95% : 1,3-1,8) et un diagnostic d’infection respiratoire (OR= 1,40, IC 95% : 1,2-1,6). L’utilisation des macrolides a été associée à une diminution du risque de prématurité (OR =0,65, IC 95% : 0,50-0,85). En revanche, les femmes ayant été exposées au métronidazole ont vu leur risque augmenté de 80% (OR=1,81, IC 95% : 1,30-2,54). L’utilisation d’azithromycine a été associée à une diminution importante du risque chez les femmes ayant un diagnostic de rupture prématurée des membranes (OR=0,31, IC 95% : 0,10-0,93). Cependant, l'utilisation de sulfaméthoxazole-triméthoprime (SXT) a été significativement associée à une augmentation du risque de SGA (OR= 1,61, IC 95% : 1,16-2,23), tandis que celle des anti-infectieux urinaires a été associée à une diminution du risque (OR= 0,80, 95%CI : 0.65-0.97). Les conclusions de nos travaux suggèrent que l’utilisation des macrolides et des pénicillines diminuent le risque de prématurité et de SGA. Nous devons considérer l'utilisation de différents choix thérapeutiques tels que l’azithromycine, lors de la prise en charge des infections pouvant induire la prématurité et le SGA. / Abstract: Anti-infective drugs are among the most used medications during pregnancy. Gestational infections are related to some adverse pregnancy outcomes, such as preterm birth and infants born small for their gestational age (SGA), which increases the risk of mortality and long-term morbidity. Given its health impacts, prompt management and treatment of these infections are warranted. However, there is some controversy on the use of anti-infective drugs to prevent adverse pregnancy outcomes, such as preterm birth. Furthermore, there is growing concern regarding its independent effects on these outcomes, when treatment of maternal infections is instituted. Therefore, we conducted 4 large population-based studies aimed to investigate the gestational use of anti-infective drugs during pregnancy and the risk of preterm birth and SGA. In addition, we systematically reviewed the available evidence on the use of metronidazole during gestation. We used data from the Quebec Pregnancy Registry, a longitudinal population-based cohort established with the linkage of three administrative databases from the province of Quebec (RAMQ, Med-Echo and ISQ). Data are available on prescriptions, pharmaceutical and healthcare services, acute care hospitalization and patient demographics. For study 1 and 2, we conducted a drug utilisation review within a cohort of 97 680 pregnant women. Study 3 and 4 were two independent case-control studies. Cases of preterm birth were defined as those with a delivery occurring before the 37th week of gestation (study 3). Cases of SGA were defined as a pregnancy resulting in a baby’s weigh adjusted for gestational age and gender <10th percentile, according to the Canadian gender-specific reference curves (Study 4). Oral use of anti-infective drugs during the last two trimesters of pregnancy was the exposure definition for both studies. Independent analyses were done to assess the risk for different classes of anti-infectives and individual agents. Our results indicate that the use of anti-infective drugs during pregnancy is prevalent (25%). Use of well-known agents increased once pregnancy was diagnosed, and the most frequent indications for use were respiratory and urinary infections. Predictors associated with use were having more that 2 different prescribers (adj. OR= 3.83, 95% CI: 3.3-4.3), having a diagnosis of urinary tract infections (adj. OR= 1.50, 95% CI: 1.3-1.8) and respiratory tract infection (adj. OR= 1.40, 95% CI: 1.2-1.6). The use of macrolides was associated with a decreased risk of preterm birth (adj. OR=0.65, 95% CI: 0.50-0.85), whereas metronidazole increased the risk (adj. OR=1.81, 95% CI: 1.30-2.54). Azithromycin had a protective effect in women with premature rupture of membranes (adj. OR=0.31, 95% CI: 0.10-0.93). Use of sulfamethoxazole/trimethoprim was associated with an increased risk of SGA (adj. OR= 1.61, 95%CI: 1.16-2.23), whereas the use of urinary anti-infectives decreased the risk (adj. OR= 0.80, 95%CI: 0.65-0.97).The results of this thesis suggest that the use of macrolides and penicillins decrease the risk of preterm birth and SGA. Health care professionals should consider other therapeutic alternatives to metronidazole and sulfonamides, such as azithromycin.

Thèse numérisée par la Division de la gestion de documents et des archives de l'Université de Montréal.

L’asthme est l’une des pathologies chroniques les plus fréquemment rencontrées durant la grossesse, affectant environ 8% des femmes enceintes. Les lignes directrices pour le traitement de l’asthme affirment que le risque d’un développement non optimal du fœtus dû à un asthme mal maîtrisé est supérieur au risque associé à la prise de médicaments pour le traitement de l’asthme durant la grossesse. Des questions persistent par contre sur l’innocuité des hautes doses de corticostéroïdes inhalés (CSI) et très peu de données sont publiées pour les bêta2-agonistes à longue action (BALA). Un programme de recherche en deux volets a été développé afin de répondre à certaines de ces questions. Dans un premier volet, une cohorte de femmes asthmatiques accouchant au Québec de 1998 à 2008 a été assemblée à partir des bases de données de la Régie de l’assurance maladie du Québec et de MED-ÉCHO afin d’évaluer l’impact de la prise de CSI ou de BALA sur la prévalence de faible poids à la naissance (FPN), de prématurité et de bébé petit pour l’âge gestationnel (PAG). La cohorte était composée de 7376 grossesses dont 56,9% étaient exposées aux CSI et 8,8% aux BALA. Dans cette cohorte, l’utilisation de BALA n’était pas associée à des prévalences plus élevées de FPN (OR=0,81, IC95%:0,58–1,12), prématurité (OR=0,84, IC95%:0,61–1,15) ou PAG (OR=0,92, IC95%:0,70–1,20). Lors de la comparaison des BALA (salmétérol comparé au formotérol comme référence) la différence la plus importante était pour le PAG (OR=1,16, IC95%:0,67–2,02). Pour les CSI, une tendance à une augmentation de FPN, prématurité et PAG a été observée avec l’augmentation des doses. Le OR le plus élevé était pour une dose > 500 ug/jour (équivalent fluticasone) pour le FPN: (OR=1,57, IC95%:0,86–2,87). La comparaison des CSI les plus utilisés (fluticasone comparé au budésonide comme référence) montre des différences non statistiquement significatives avec la différence maximale observée pour le PAG (OR=1,10, IC95%:0,85–1,44). Dans un second volet, une sous-cohorte de femmes asthmatiques avec visites médicales pour exacerbation d’asthme au Centre hospitalier universitaire de Sherbrooke (CHUS) a été constituée pour comparer le traitement des exacerbations durant et hors grossesse. Les résultats montrent que le traitement par CS était moins fréquent et différé pour les femmes enceintes comparées aux femmes non-enceintes. Le traitement de maîtrise de l’asthme (CSI et/ou BALA) dans l’année précédant l’exacerbation était sous-optimal. Les résultats présentés dans cette thèse démontrent l’innocuité des BALA et des doses faibles à modérées de CSI pendant la grossesse pour les issues de FPN, prématurité et PAG alors que des études supplémentaires sont nécessaires afin d’évaluer l’innocuité des hautes doses de CSI. Une innocuité comparable entre les CSI (budésonide, fluticasone) et les BALA étudiés (formotérol, salmétérol) a également été démontrée. Les résultats montrent également un recours moindre aux CS pour le traitement des exacerbations d’asthme durant la grossesse comparativement à hors grossesse. Ces résultats sont un ajout important aux évidences permettant aux cliniciens et aux femmes enceintes asthmatiques de faire les meilleurs choix pour optimiser le traitement pharmacologique durant la grossesse. / Asthma is one of the most common chronic medical conditions encountered during pregnancy, affecting approximately 8% of pregnant women. Current asthma treatment guidelines emphasize the importance and safety of the use of asthma medications during pregnancy compared to the risk of poorly controlled asthma for the fetus. In the evaluation of the safety of asthma medications during pregnancy, the literature review shows that questions persist, amongst others, on the safety of high inhaled corticosteroids (ICSs) doses and that there is a paucity of data on the safety of long-acting beta2-agonists (LABAs). A two components research program was developed to answers some of these questions. In the first component, a cohort of asthmatic women giving birth from 1998 to 2008 was constructed from the Régie de l’assurance maladie du Québec (RAMQ) et de MED-ÉCHO databases to assess the impact of the use of long-acting β2-agonists (LABAs) and the dose of inhaled corticosteroids (ICSs) during pregnancy on the prevalence of low birth weight (LBW), preterm birth (PB), and small for gestational age (SGA). The cohort included 7,376 pregnancies: 8.8% exposed to LABAs and 56.9% exposed to ICSs. LABA use was not found to be associated with increased prevalence of LBW (OR=0.81; 95%CI: 0.58–1.12), PB (OR=0.84; 95%CI: 0.61–1.15), or SGA (OR=0.92; 95%CI: 0.70–1.20). In the LABAs comparison (salmeterol compared to formoterol as reference), the most important difference was observed for PAG (OR=1.16, 95%CI: 0.67–2.02). For the ICSs, increasing doses were associated with a trend of increased LBW, PB, and SGA. The maximal observed OR was for a dose > 500 ug/day (fluticasone-equivalent) for LBW: (OR=1.57, 95%CI: 0.86–2.87). The comparison of the most frequently used ICSs (fluticasone compared to budesonide as reference) revealed non-statistically significant differences with a maximal difference observed for SGA (OR=1.10, 95%CI: 0.85–1.44). In the second component, a sub-cohort of asthmatic women with medical visits for asthma exacerbations was constructed to compare the treatment of exacerbations during and outside of pregnancy. The results show a reduced and delayed use of systemic corticosteroids for the treatment of asthma exacerbations in women when pregnant than when non-pregnant. The preventive treatment of asthma (ICSs and/or BALAs) could also be optimized. The results presented in this thesis support the safety of the use during pregnancy of LABAs and low to moderate doses of ICSs for the outcomes of LBW, PB and SGA and point to the need for additional data on the safety of high ICS doses. A comparable safety between studied ICSs (budesonide and fluticasone) and BALAs (formoterol and salmeterol) was also demonstrated. We also observed a reduced and delayed use of systemic corticosteroids for the treatment of asthma exacerbations in women when pregnant than when non-pregnant.

Introdução: O nascimento de recém-nascidos pré-termo tardios (RNPT-T), geralmente tratados como \"quase termo\", vem aumentando nas últimas décadas. Vários fatores são atríbuídos à sua etiologia e contribuem para aumentar as taxas de morbimortalidade perinatal e infantil. Atualmente se dispõe de poucos estudos sobre esses recém-nascidos, especialmente sobre o seu crescimento. Objetivos: Analisar o crescimento de RNPT-T nos seis primeiros meses de idade corrigida. Métodos: Estudo observacional, analítico de uma coorte de 64 RNPT-T, coletados nos quatro maiores hospitais de Cuiabá, entre janeiro e setembro de 2013 e acompanhados até 6 meses de idade corrigida. Os dados foram coletados ao nascer, às 40 semanas, 3 e 6 meses de idade corrigida. Foram realizadas análises de correlação entre os parâmetros antropométricos perímetro braquial (PB) e prega cutânea tricipital (PCT) em função dos índices antropométricos PB/PC (perímetro cefálico), peso/comprimento (P/C) e Índice de Massa Corpórea (IMC) e realizada regressão linear múltipla. Resultados: Ao nascimento, 81,3% foram classificados como adequados para a idade gestacional, com a média de peso de 2343,80g ± 430,50. Todos os recém-nascidos apresentaram crescimento contínuo nos seis meses de idade corrigida para os valores de peso, comprimento e perímetro cefálico (PC). Já os valores médios de PCT, de PB/PC e de IMC não mostraram diferença aos 6 meses de idade corrigida. Todos os coeficientes de correlação (r) dos parâmetros PCT e PB em relação aos índices antropométricos apresentaram significância estatística, sendo os valores mais altos para PB versus PB/PC e P/C e menores para PB versus IMC. No modelo final da regressão linear múltipla da PCT, o PB/PC contribuiu significantemente para predizer o depósito de gordura ao nascimento, às 40 semanas e aos 3 meses de idade corrigida (33,8%%, 46,07% e 18,08% respectivamente); aos 6 meses o melhor preditor foi a razão P/C (10,45%). O melhor preditor para o PB foi o PB/PC, que permaneceu no modelo com valores de 73,71%% em todos os tempos avaliados. Conclusão: Os parâmetros peso, comprimento, perímetro cefálico e perímetro braquial e a relação P/C aumentaram nos quatro tempos de aferição, enquanto o PCT e as relações PB/PC e IMC não se modificaram do primeiro para o segundo trimestre e o PB/PC foi o melhor preditor do depósito de gordura subcutânea tricipital (PCT) e de massa gorda e muscular (PB) / Introduction: The birth of newborns late preterm (RNPT -T), usually treated as \"near term\", has been increasing in recent decades. Several factors are attributed to its etiology and contribute to increased rates of perinatal and infant morbidity and mortality. Currently there are few studies of these newborns, especially about their growth. Objectives: To analyze the growth pattern of late preterm infants from birth to six months of corrected age. Methods: This cohort study included 64 RNPT-T, in four major hospitals in Cuiabá, between January and September 2013 and followed until 6 months corrected age. Data were collected at birth, at 40 weeks, 3 and 6 months corrected age. Correlation analyzes between anthropometric parameters mid- arm circumference (MAC) and triceps skinfold (TS) on the basis of anthropometric indices MAC / HC (head circumference), weight / length (W / L) and body mass index (BMI) were performed multiple linear regression. Results: At birth, 81.3 % were classified as appropriate for gestational age, with the average weight of 2343.80 ± 430.50 g. All newborns had a continuous growth in the six months corrected age for the values of weight, length and head circumference (HC). The average value of TS values of MAC / HC and BMI showed no difference at 6 months of corrected age. All correlation coefficients (r) of the TS and MAC parameters in relation to anthropometric indices showed statistically significant, with the highest values for MAC versus MAC / HC and W / L and lower for MAC versus BMI. At the end of the TS model of multiple linear regression, the MAC / HC contributed significantly to predict the deposition of fat at birth, at 40 weeks and at 3 months\' corrected age (33.8 %, 46.07 % and 18.08 % respectively); at 6 months was the best predictor of the ratio W/ L (10.45%). The best predictor for the MAC was the MAC / HC, which remained in the model with values of 73.71 % at all evaluated times. Conclusion: The parameters weight, length, head circumference and arm - circumference and the ratio W / L increased in the four times of measurement, while the TS and MUAC / HC relations and BMI did not change from the first to the second quarter and MAC / HC was the best predictor of subcutaneous fat deposit triceps (TS) and fat and muscle (MAC) mass

A gemelaridade apresenta algumas intercorrências específicas, como a discordância de peso entre fetos e recém-nascidos (RNs). O objetivo do presente estudo foi predizer a discordância de peso do exame ultra-sonográfico comparada à do parto e avaliar a morbidade e a mortalidade neonatais nas gestações gemelares discordantes quanto ao peso. Este foi um estudo retrospectivo, com levantamento dos casos do período de 1998 a 2004, no Setor de Gestações Múltiplas da Clínica Obstétrica do HCFMUSP. Na avaliação da predição ultra-sonográfica, foram inseridas 221 gestações gemelares e, na avaliação da morbidade e da mortalidade, 151 gestações com partos nessa instituição. A discordância de peso foi definida como >= 20%, sendo excluídos os casos de malformações fetais (n=43) e da Síndrome da transfusão feto-fetal (n=24). Para análise da adequação do peso ao nascimento, utilizou-se a curva de Alexander et al., 1998, para gêmeos. No estudo da predição, foram utilizados quatro intervalos de tempo em relação ao parto (0 a 7 dias - n = 96; 8 a 14 dias - n = 66; 15 a 21 dias - n = 58; 22 a 28 dias - n = 59 gestações), somando 279 avaliações. No grupo de 0 a 7 dias, a estimativa da sensibilidade foi de 93,6%, especificidade de 79,4%, valor preditivo positivo de 89,2%, valor preditivo negativo de 87,1% e acurácia de 88,6%. Nos demais grupos, a sensibilidade e a acurácia foram de 95,8% e 84,9%, 95,6% e 84,5%, 90,9% e 84,8%, respectivamente. Em relação à morbidade, 111 gestações eram concordantes (73,5%) e 40 discordantes quanto ao peso. No grupo discordante, 75% das gestações gemelares apresentaram pelo menos um recém-nascido com Restrição de Crescimento Fetal (RCF). Nesta análise, as gestações gemelares concordantes monocoriônicas obtiveram menor média de idade gestacional no parto (34,3 versus 36,2 semanas, p=0,004), menor peso médio (2067 versus 2334 gramas, p=0,0016) e maior tempo de internação (10,6 versus 7,3 dias, p=0,0023) que as gestações concordantes dicoriônicas. Nas gestações discordantes, não houve diferença significativa em relação à corionicidade. As gestações discordantes, com pelo menos um RN abaixo do percentil 10, apresentaram menor média de idade gestacional (35,2 versus 36,8 semanas, p=0,009) e maior tempo de internação (17,5 versus 8,2 dias, p=0,026). Não foi observada diferença significativa de morbidade e mortalidade entre RNs concordantes e discordantes, com pesos entre os percentis 10 e 90. Os fetos menores das gestações discordantes demonstraram maior freqüência de índice de Apgar inferior a 7 (27,5% versus 7,5%, p=0,01). A avaliação da mortalidade não demonstrou diferença significativa em relação aos grupos concordantes (3,7%) e discordantes (4,5%; p = 1,00). No presente estudo, conclui-se que os quatro grupos apresentaram adequada correlação entre a discordância de peso à ultra-sonografia e no nascimento, porém com melhor predição até sete dias antes do parto. A morbidade neonatal esteve relacionada à RCF do menor feto. A discordância de peso e a corionicidade não interferiram na mortalidade neonatal. / The aim of this study was to evaluate the ability of prenatal ultrasound scans to predict fetal growth discordance in twin pregnancies and perinatal morbidity/mortality associated with these cases. This was a retrospective study (1998-2004) involving twin pregnancies that were scanned and had their delivery at our Institution (HCFMUSP). Cases with fetal malformations (n=43) or twin to twin transfusion syndrome (n=24) were excluded. The study of ultrasound scans consisted of 221 twin pregnancies. The final morbidity/mortality study group consisted of 151 twin pregnancies. Birth weight was evaluated based on twin growth charts published by Alexander et al (1998) and weight discordance as a difference >= 20%. Small for gestacional age (SGA) was defined as birth weight below the 10th centile. The study of ultrasonographic prediction of interwin discordance was made using four different intervals between ultrasound examination and delivery (0 to 7 days, n = 96; 8 to 14 days, n = 66; 15 to 21 days, n = 58; 22 to 28 days, n = 59 pregnancies), with a total of 279 ultrasound examinations. In group 0 to 7 days, the sensitivity was 93,6%, specificity was 79,4%, positive predicted values was 89,2%, negative predicted values was 87,1% and accuracy was 88,6%. In the groups 8 to 14 days, 15 to 21 days and 22 to 28 days the sensitivity and accuracy were 95,8% and 84,9%, 95,6% and 84,5%, 90,9% and 84,8%, respectively. Birthweight discordance was observed in 40 sets of twins (26.5%) and 12 cases were monochorionic MC (30%). Twenty five cases (22.5%) in the non discordant group were MC. In the non discordant group, monochorionic pregnancies showed lower gestational age at delivery (34.3 versus 36.2 wks, p=0.004), lower mean birth weight (2067g versus 2334g, p=0.0016) and longer length of stay in hospital (10.6 versus 7.3 days, p=0.0023) compared to dichorionic twins. In the group with twin birthweight discordance, there were no significant differences between MC and DC pregnancies and 75% of the cases had at least one newborn with SGA. These cases were showed lower gestational age at delivery (35.2 versus 36.8wks, p=0.009) and longer length of stay in hospital (17.5 versus 8.2 days, p=0.026). In the discordant group, the smaller twin had a higher frequency of first minute Apgar score < 7 (27.5% versus 7.5%, p=0.01). Perinatal mortality rate was similar in both groups (discordant 4.5% and concordant 3.7%, p=1.0). There were no significant differences in morbidity and mortality between concordant and discordant twins when birth weight was between the 10 th and 90 th centile. In conclusion, there was a good correlation between fetal growth discordance predicted by prenatal scan and actual birth weight discordance. Neonatal morbidity was related to SGA. Excluding fetal malformation and TTTS cases, birth weight discordance in twin pregnancies is not a significantly associated with neonatal mortality.

As gestações gemelares monocoriônicas e diamnióticas (MCDA) apresentam maior risco de restrição de crescimento fetal (RCF) e complicações perinatais. O objetivo deste estudo foi avaliar a morbidade e mortalidade perinatal em gestações gemelares MCDA: na presença de RCF e dopplervelocimetria de artéria umbilical normal e anormal; nos diferentes padrões de dopplervelocimetria de artéria umbilical (doppler normal, índice de pulsatilidade aumentado, fluxo diastólico intermitente de artéria umbilical, diástole zero e diástole reversa) e na presença de RCF seletiva e não seletiva. Estudo retrospectivo, com levantamento dos casos no período entre 2004 e 2011, no Setor de Gestações Múltiplas da Clínica Obstétrica do HCFMUSP. Desta forma, foram inseridas 48 gestações gemelares, com 60 fetos abaixo do percentil 10 de uma curva específica para gêmeos. Casos que apresentaram malformações fetais (n=36) ou síndrome da transfusão fetofetal (n=43) não foram incluídos no estudo. O grupo com RCF e dopplervelocimetria anormal apresentou menor média de idade gestacional no parto (33,39 versus 35,48, p <0,001), menor média de peso ao nascimento (1137,12 gramas versus 1675,77 gramas, p < 0,001), maior frequência de internação em Unidade de terapia intensiva (UTI) neonatal (69,23% versus 19,23%, p = 0,0003), maior frequência de doença respiratória (73,08 versus 34,62, p = 0,005) e maior frequência de óbito intrauterino e neonatal (p = 0,025). Na avaliação dos diferentes padrões de dopplervelocimetria da artéria umbilical (normal, índice de pulsatilidade aumentado, fluxo diastólico intermitente, diástole zero e diástole reversa), os grupos diferiram em relação à média da idade gestacional no parto (35,48; 34,22; 33,33; 33,15 e 32,45 semanas, p < 0,001), frequência de internação em UTI neonatal (19,23; 50,00; 50,00; 85,71 e 100,00%, p < 0,001) e desfecho com alta hospitalar (96,15; 100,00; 83,33; 71,43 e 25,00%, p < 0,001). O grupo com diástole reversa apresentou os piores resultados perinatais. Na avaliação da RCF seletiva, não foi observada diferença significativa em relação à idade gestacional no parto (33,4 versus 33,4, p = 0,953), mas houve maior necessidade de intubação orotraqueal (62,5% versus 32,3%, p = 0,001) e ventilação mecânica (75,0% versus 41,2%, p = 0,0006) em relação ao grupo de RCF não seletiva. No grupo RCF seletiva houve maior número de casos de dopplervelocimetria de artéria umbilical com índice de pulsatilidade aumentada, fluxo intermitente, diástole zero e reversa (p = 0,005). Como conclusão o estudo demonstrou maior morbidade e mortalidade perinatal no grupo com dopplervelocimetria anormal com diferença significativa em relação aos padrões distintos de dopplervelocimetria e piores resultados na presença de diástole reversa. O grupo de RCF seletiva apresentou maior frequência de anormalidades na dopplervelocimetria de artéria umbilical e morbidade neonatal em relação ao grupo com RCF não seletiva / Monochorionic diamniotic (MCDA) twin pregnancies have and increased risk for intrauterine growth restriction (IUGR) and perinatal complications. The aim of this study is to evaluate perinatal morbidity and mortality in MCDA twin pregnancies: in the presence of IUGR with normal and abnormal umbilical artery dopplervelocimetry; in different umbilical artery flow patterns (normal dopplervelocimetry, increased pulsatility index, intermittent flow pattern, absent end diastolic flow and reversed end diastolic flow) and in the presence of selective and non-selective IUGR. This was a retrospective study in the Multiple Pregnancy Unit at the Obstetric Clinic of HCFMUSP, between 2004 and 2011. The study included 48 twin pregnancies, where 60 fetuses weighted less than the 10th percentile according to twins charts. Cases with fetal malformation (n=36) or twin to twin transfusion syndrome (n=43) were not included in the study. The group with IUGR and abnormal umbilical artery Doppler presented lower mean gestational age at delivery (33.39 versus 35.48, p <0.001), lower mean birthweight (1137.12 g versus 1675.77 g, p < 0.001), higher need of neonatal intensive care unit (NICU, 69.23% versus 19.23%, p = 0.0003), higher frequency of respiratory disease (73.08 versus 34.62, p = 0.005) and higher incidence of intrauterine and neonatal death (p = 0.025). In the different umbilical artery flow patterns (normal dopplervelocimetry, increased pulsatility index, intermittent flow pattern, absent end diastolic flow and reversed end diastolic flow) the group differ in relation to gestational age at delivery (35.48; 34.22; 33.33; 33.15 and 32.45 weeks; p < 0.001), need of NICU (19.23; 50.00; 50.00; 85.71 and 100,00%; p < 0.001) and alive at hospital discharge (96.15; 100,00; 83.33; 71.43 and 25,00%; p < 0.001). The group with reversed and diastolic flow presented the worse perinatal outcome. In the selective and non-selective IUGR groups, no difference was observed in relation to gestational age at delivery (33.4 versus 33.4 weeks, p = 0.953), however there was higher need for orotracheal intubation (62.5% versus 32.3%, p = 0.001) and mechanical ventilation (75.0% versus 41.2%, p = 0.0006) in the selective IUGR group. Abnormal umbilical artery Doppler such as increased pulsatility index, intermittent blood flow, absent and reversed flow were more frequent in the selective IUGR group (p = 0.005). As conclusion, the study demonstrated higher perinatal morbidity and mortality in the IUGR group with abnormal umbilical artery Doppler with significant difference in relation to Doppler patterns and the worse outcome was related to reversed diastolic flow pattern. The selective IUGR group presents higher frequency of abnormal umbilical artery dopplervelocimetry and neonatal morbidity compared to non- selective IUGR group

Introdução: O nascimento de recém-nascidos pré-termo tardios (RNPT-T), geralmente tratados como \"quase termo\", vem aumentando nas últimas décadas. Vários fatores são atríbuídos à sua etiologia e contribuem para aumentar as taxas de morbimortalidade perinatal e infantil. Atualmente se dispõe de poucos estudos sobre esses recém-nascidos, especialmente sobre o seu crescimento. Objetivos: Analisar o crescimento de RNPT-T nos seis primeiros meses de idade corrigida. Métodos: Estudo observacional, analítico de uma coorte de 64 RNPT-T, coletados nos quatro maiores hospitais de Cuiabá, entre janeiro e setembro de 2013 e acompanhados até 6 meses de idade corrigida. Os dados foram coletados ao nascer, às 40 semanas, 3 e 6 meses de idade corrigida. Foram realizadas análises de correlação entre os parâmetros antropométricos perímetro braquial (PB) e prega cutânea tricipital (PCT) em função dos índices antropométricos PB/PC (perímetro cefálico), peso/comprimento (P/C) e Índice de Massa Corpórea (IMC) e realizada regressão linear múltipla. Resultados: Ao nascimento, 81,3% foram classificados como adequados para a idade gestacional, com a média de peso de 2343,80g ± 430,50. Todos os recém-nascidos apresentaram crescimento contínuo nos seis meses de idade corrigida para os valores de peso, comprimento e perímetro cefálico (PC). Já os valores médios de PCT, de PB/PC e de IMC não mostraram diferença aos 6 meses de idade corrigida. Todos os coeficientes de correlação (r) dos parâmetros PCT e PB em relação aos índices antropométricos apresentaram significância estatística, sendo os valores mais altos para PB versus PB/PC e P/C e menores para PB versus IMC. No modelo final da regressão linear múltipla da PCT, o PB/PC contribuiu significantemente para predizer o depósito de gordura ao nascimento, às 40 semanas e aos 3 meses de idade corrigida (33,8%%, 46,07% e 18,08% respectivamente); aos 6 meses o melhor preditor foi a razão P/C (10,45%). O melhor preditor para o PB foi o PB/PC, que permaneceu no modelo com valores de 73,71%% em todos os tempos avaliados. Conclusão: Os parâmetros peso, comprimento, perímetro cefálico e perímetro braquial e a relação P/C aumentaram nos quatro tempos de aferição, enquanto o PCT e as relações PB/PC e IMC não se modificaram do primeiro para o segundo trimestre e o PB/PC foi o melhor preditor do depósito de gordura subcutânea tricipital (PCT) e de massa gorda e muscular (PB) / Introduction: The birth of newborns late preterm (RNPT -T), usually treated as \"near term\", has been increasing in recent decades. Several factors are attributed to its etiology and contribute to increased rates of perinatal and infant morbidity and mortality. Currently there are few studies of these newborns, especially about their growth. Objectives: To analyze the growth pattern of late preterm infants from birth to six months of corrected age. Methods: This cohort study included 64 RNPT-T, in four major hospitals in Cuiabá, between January and September 2013 and followed until 6 months corrected age. Data were collected at birth, at 40 weeks, 3 and 6 months corrected age. Correlation analyzes between anthropometric parameters mid- arm circumference (MAC) and triceps skinfold (TS) on the basis of anthropometric indices MAC / HC (head circumference), weight / length (W / L) and body mass index (BMI) were performed multiple linear regression. Results: At birth, 81.3 % were classified as appropriate for gestational age, with the average weight of 2343.80 ± 430.50 g. All newborns had a continuous growth in the six months corrected age for the values of weight, length and head circumference (HC). The average value of TS values of MAC / HC and BMI showed no difference at 6 months of corrected age. All correlation coefficients (r) of the TS and MAC parameters in relation to anthropometric indices showed statistically significant, with the highest values for MAC versus MAC / HC and W / L and lower for MAC versus BMI. At the end of the TS model of multiple linear regression, the MAC / HC contributed significantly to predict the deposition of fat at birth, at 40 weeks and at 3 months\' corrected age (33.8 %, 46.07 % and 18.08 % respectively); at 6 months was the best predictor of the ratio W/ L (10.45%). The best predictor for the MAC was the MAC / HC, which remained in the model with values of 73.71 % at all evaluated times. Conclusion: The parameters weight, length, head circumference and arm - circumference and the ratio W / L increased in the four times of measurement, while the TS and MUAC / HC relations and BMI did not change from the first to the second quarter and MAC / HC was the best predictor of subcutaneous fat deposit triceps (TS) and fat and muscle (MAC) mass

As gestações gemelares monocoriônicas e diamnióticas (MCDA) apresentam maior risco de restrição de crescimento fetal (RCF) e complicações perinatais. O objetivo deste estudo foi avaliar a morbidade e mortalidade perinatal em gestações gemelares MCDA: na presença de RCF e dopplervelocimetria de artéria umbilical normal e anormal; nos diferentes padrões de dopplervelocimetria de artéria umbilical (doppler normal, índice de pulsatilidade aumentado, fluxo diastólico intermitente de artéria umbilical, diástole zero e diástole reversa) e na presença de RCF seletiva e não seletiva. Estudo retrospectivo, com levantamento dos casos no período entre 2004 e 2011, no Setor de Gestações Múltiplas da Clínica Obstétrica do HCFMUSP. Desta forma, foram inseridas 48 gestações gemelares, com 60 fetos abaixo do percentil 10 de uma curva específica para gêmeos. Casos que apresentaram malformações fetais (n=36) ou síndrome da transfusão fetofetal (n=43) não foram incluídos no estudo. O grupo com RCF e dopplervelocimetria anormal apresentou menor média de idade gestacional no parto (33,39 versus 35,48, p <0,001), menor média de peso ao nascimento (1137,12 gramas versus 1675,77 gramas, p < 0,001), maior frequência de internação em Unidade de terapia intensiva (UTI) neonatal (69,23% versus 19,23%, p = 0,0003), maior frequência de doença respiratória (73,08 versus 34,62, p = 0,005) e maior frequência de óbito intrauterino e neonatal (p = 0,025). Na avaliação dos diferentes padrões de dopplervelocimetria da artéria umbilical (normal, índice de pulsatilidade aumentado, fluxo diastólico intermitente, diástole zero e diástole reversa), os grupos diferiram em relação à média da idade gestacional no parto (35,48; 34,22; 33,33; 33,15 e 32,45 semanas, p < 0,001), frequência de internação em UTI neonatal (19,23; 50,00; 50,00; 85,71 e 100,00%, p < 0,001) e desfecho com alta hospitalar (96,15; 100,00; 83,33; 71,43 e 25,00%, p < 0,001). O grupo com diástole reversa apresentou os piores resultados perinatais. Na avaliação da RCF seletiva, não foi observada diferença significativa em relação à idade gestacional no parto (33,4 versus 33,4, p = 0,953), mas houve maior necessidade de intubação orotraqueal (62,5% versus 32,3%, p = 0,001) e ventilação mecânica (75,0% versus 41,2%, p = 0,0006) em relação ao grupo de RCF não seletiva. No grupo RCF seletiva houve maior número de casos de dopplervelocimetria de artéria umbilical com índice de pulsatilidade aumentada, fluxo intermitente, diástole zero e reversa (p = 0,005). Como conclusão o estudo demonstrou maior morbidade e mortalidade perinatal no grupo com dopplervelocimetria anormal com diferença significativa em relação aos padrões distintos de dopplervelocimetria e piores resultados na presença de diástole reversa. O grupo de RCF seletiva apresentou maior frequência de anormalidades na dopplervelocimetria de artéria umbilical e morbidade neonatal em relação ao grupo com RCF não seletiva / Monochorionic diamniotic (MCDA) twin pregnancies have and increased risk for intrauterine growth restriction (IUGR) and perinatal complications. The aim of this study is to evaluate perinatal morbidity and mortality in MCDA twin pregnancies: in the presence of IUGR with normal and abnormal umbilical artery dopplervelocimetry; in different umbilical artery flow patterns (normal dopplervelocimetry, increased pulsatility index, intermittent flow pattern, absent end diastolic flow and reversed end diastolic flow) and in the presence of selective and non-selective IUGR. This was a retrospective study in the Multiple Pregnancy Unit at the Obstetric Clinic of HCFMUSP, between 2004 and 2011. The study included 48 twin pregnancies, where 60 fetuses weighted less than the 10th percentile according to twins charts. Cases with fetal malformation (n=36) or twin to twin transfusion syndrome (n=43) were not included in the study. The group with IUGR and abnormal umbilical artery Doppler presented lower mean gestational age at delivery (33.39 versus 35.48, p <0.001), lower mean birthweight (1137.12 g versus 1675.77 g, p < 0.001), higher need of neonatal intensive care unit (NICU, 69.23% versus 19.23%, p = 0.0003), higher frequency of respiratory disease (73.08 versus 34.62, p = 0.005) and higher incidence of intrauterine and neonatal death (p = 0.025). In the different umbilical artery flow patterns (normal dopplervelocimetry, increased pulsatility index, intermittent flow pattern, absent end diastolic flow and reversed end diastolic flow) the group differ in relation to gestational age at delivery (35.48; 34.22; 33.33; 33.15 and 32.45 weeks; p < 0.001), need of NICU (19.23; 50.00; 50.00; 85.71 and 100,00%; p < 0.001) and alive at hospital discharge (96.15; 100,00; 83.33; 71.43 and 25,00%; p < 0.001). The group with reversed and diastolic flow presented the worse perinatal outcome. In the selective and non-selective IUGR groups, no difference was observed in relation to gestational age at delivery (33.4 versus 33.4 weeks, p = 0.953), however there was higher need for orotracheal intubation (62.5% versus 32.3%, p = 0.001) and mechanical ventilation (75.0% versus 41.2%, p = 0.0006) in the selective IUGR group. Abnormal umbilical artery Doppler such as increased pulsatility index, intermittent blood flow, absent and reversed flow were more frequent in the selective IUGR group (p = 0.005). As conclusion, the study demonstrated higher perinatal morbidity and mortality in the IUGR group with abnormal umbilical artery Doppler with significant difference in relation to Doppler patterns and the worse outcome was related to reversed diastolic flow pattern. The selective IUGR group presents higher frequency of abnormal umbilical artery dopplervelocimetry and neonatal morbidity compared to non- selective IUGR group